1. Diabetic retinopathy (diagnostics, therapy, classification)

2. Diabetes mellitus- definition Diabetes mellitus is disease with high glucose level (hyperglycaemia) due to absolute or relative lack of insulin produced in beta cells of Langerhans pancreatic isletsDiabetes mellitus is disease with high glucose level (hyperglycaemia) due to absolute or relative lack of insulin produced in beta cells of Langerhans pancreatic islets

3. Diabetes mellitus- classification  Diabetes type 1  Diabetes type 2  Gestational diabetes  Diabetes type 1  Diabetes type 2  Gestational diabetes

4. Epidemiology of diabetes (CZ in 2009) 800 000800 000 8% of population8% of population -DM type 18% -DM type 292% 800 000800 000 8% of population8% of population -DM type 18% -DM type 292%

5. Pathogenesis of diabetes type 1 The destruction of insulin-producing beta- cells of pancreatic islets of LangerhansThe destruction of insulin-producing beta- cells of pancreatic islets of Langerhans (autoimmune process, a genetic predisposition, external environmental factor, in the second of identical twins diabetes arises only in 50% of cases) (autoimmune process, a genetic predisposition, external environmental factor, in the second of identical twins diabetes arises only in 50% of cases) The destruction of insulin-producing beta- cells of pancreatic islets of LangerhansThe destruction of insulin-producing beta- cells of pancreatic islets of Langerhans (autoimmune process, a genetic predisposition, external environmental factor, in the second of identical twins diabetes arises only in 50% of cases) (autoimmune process, a genetic predisposition, external environmental factor, in the second of identical twins diabetes arises only in 50% of cases)

6. Pathogenesis of diabetes type 2 Failure of insulin secretion in pancreatic beta-cells Reduction of insulin action in target tissues (insulin resistance)Failure of insulin secretion in pancreatic beta-cells Reduction of insulin action in target tissues (insulin resistance)

7. InsulinInsulin discovered 1921 (Banting, Best, Macleod, Collip)

8.  hyperglycaemic ketoacidotic coma hyperglycaemic hyperosmolar coma lactacidotic coma hypoglycaemic coma Diabetes mellitus (acute complications)

9. Diabetes mellitus (late complications) 1.retinopathy 2.nephropathy 3.diabetic foot 4.neuropathy 1.retinopathy 2.nephropathy 3.diabetic foot 4.neuropathy

10. Diabetes mellitus (therapy) EducationEducation DietDiet Oral antidiabeticsOral antidiabetics InsulinInsulin EducationEducation DietDiet Oral antidiabeticsOral antidiabetics InsulinInsulin

11. Diabetic retinopathy (definition) Diabetic retinopathy is microangiopathy, ie. retinal vascular impairment in diabetic patientsDiabetic retinopathy is microangiopathy, ie. retinal vascular impairment in diabetic patients

12. Diabetic retinopathy (history) DM first description– Ebers papyrus (1550 before Ch.), Aretaios from Kappadokia (2th century)DM first description– Ebers papyrus (1550 before Ch.), Aretaios from Kappadokia (2th century) DR was first described after Helmholtz ophthalmoscope discovery (1851)DR was first described after Helmholtz ophthalmoscope discovery (1851) First description of DR – Jäger (1851), Desmarres (1855), von Gräfe (1858)First description of DR – Jäger (1851), Desmarres (1855), von Gräfe (1858) First classification of DR – Ballantyn a Löwensteine (1943), nonproliferative and proliferative DRFirst classification of DR – Ballantyn a Löwensteine (1943), nonproliferative and proliferative DR DM first description– Ebers papyrus (1550 before Ch.), Aretaios from Kappadokia (2th century)DM first description– Ebers papyrus (1550 before Ch.), Aretaios from Kappadokia (2th century) DR was first described after Helmholtz ophthalmoscope discovery (1851)DR was first described after Helmholtz ophthalmoscope discovery (1851) First description of DR – Jäger (1851), Desmarres (1855), von Gräfe (1858)First description of DR – Jäger (1851), Desmarres (1855), von Gräfe (1858) First classification of DR – Ballantyn a Löwensteine (1943), nonproliferative and proliferative DRFirst classification of DR – Ballantyn a Löwensteine (1943), nonproliferative and proliferative DR

13. First retinal fotocoagulation– Meyer-Schwickerath (1945), solar photocoagulator (heliostat)First retinal fotocoagulation– Meyer-Schwickerath (1945), solar photocoagulator (heliostat) Regression of proliferative DR after postpartual hypophysal necrosis (1953) – Simmonds- Sheehan syndromeRegression of proliferative DR after postpartual hypophysal necrosis (1953) – Simmonds- Sheehan syndrome Discovery of fluorescence angiography – Novotny, Alvis (1959)Discovery of fluorescence angiography – Novotny, Alvis (1959) First retinal fotocoagulation– Meyer-Schwickerath (1945), solar photocoagulator (heliostat)First retinal fotocoagulation– Meyer-Schwickerath (1945), solar photocoagulator (heliostat) Regression of proliferative DR after postpartual hypophysal necrosis (1953) – Simmonds- Sheehan syndromeRegression of proliferative DR after postpartual hypophysal necrosis (1953) – Simmonds- Sheehan syndrome Discovery of fluorescence angiography – Novotny, Alvis (1959)Discovery of fluorescence angiography – Novotny, Alvis (1959) Diabetic retinopathy (history)

14. First use of laser– Meyer-Schwickerath (1955-1958), xenon lampFirst use of laser– Meyer-Schwickerath (1955-1958), xenon lamp Rubine laser (1960)Rubine laser (1960) Argon laser (1968)Argon laser (1968) Pars plana vitrectomy – Machemer, Parel (1970)Pars plana vitrectomy – Machemer, Parel (1970) Fluorophotometry – Cunha-Vaz (1975), preretinopathyFluorophotometry – Cunha-Vaz (1975), preretinopathy First use of laser– Meyer-Schwickerath (1955-1958), xenon lampFirst use of laser– Meyer-Schwickerath (1955-1958), xenon lamp Rubine laser (1960)Rubine laser (1960) Argon laser (1968)Argon laser (1968) Pars plana vitrectomy – Machemer, Parel (1970)Pars plana vitrectomy – Machemer, Parel (1970) Fluorophotometry – Cunha-Vaz (1975), preretinopathyFluorophotometry – Cunha-Vaz (1975), preretinopathy Diabetic retinopathy (history)

15. 1976- Diabetic Retinopathy Study (DRS)- laser reduces risk of blidness in proliferative DR1976- Diabetic Retinopathy Study (DRS)- laser reduces risk of blidness in proliferative DR 1985- Early Treatment Diabetic Retinopathy Study (ETDRS)- focal laser photocoagulation reduces risc of visual acuity lost in diabetic macular edema1985- Early Treatment Diabetic Retinopathy Study (ETDRS)- focal laser photocoagulation reduces risc of visual acuity lost in diabetic macular edema 1976- Diabetic Retinopathy Study (DRS)- laser reduces risk of blidness in proliferative DR1976- Diabetic Retinopathy Study (DRS)- laser reduces risk of blidness in proliferative DR 1985- Early Treatment Diabetic Retinopathy Study (ETDRS)- focal laser photocoagulation reduces risc of visual acuity lost in diabetic macular edema1985- Early Treatment Diabetic Retinopathy Study (ETDRS)- focal laser photocoagulation reduces risc of visual acuity lost in diabetic macular edema Diabetická retinopatie (historie)

16. Diabetes mellitus- 8% populationDiabetes mellitus- 8% population 25% diabetics - DR25% diabetics - DR 5% diabetics - proliferative DR5% diabetics - proliferative DR DR rare until first 3-5 years of duration of DMDR rare until first 3-5 years of duration of DM DR in 60- 90% after 15- 20 years of duration of DMDR in 60- 90% after 15- 20 years of duration of DM DR in 97% after 30 years of duration of DMDR in 97% after 30 years of duration of DM Diabetes mellitus- 8% populationDiabetes mellitus- 8% population 25% diabetics - DR25% diabetics - DR 5% diabetics - proliferative DR5% diabetics - proliferative DR DR rare until first 3-5 years of duration of DMDR rare until first 3-5 years of duration of DM DR in 60- 90% after 15- 20 years of duration of DMDR in 60- 90% after 15- 20 years of duration of DM DR in 97% after 30 years of duration of DMDR in 97% after 30 years of duration of DM Diabetic retinopathy (epidemiology)

17. Patophysiology of diabetic retinopathy

18. MicroangiopathyMicroangiopathy Lost of endothelial cells and pericitesLost of endothelial cells and pericites Thickening of basal membrane of retinal capillaries (glycoproteins)Thickening of basal membrane of retinal capillaries (glycoproteins) Failure of outer and inner blood retinal barrierFailure of outer and inner blood retinal barrier MicroangiopathyMicroangiopathy Lost of endothelial cells and pericitesLost of endothelial cells and pericites Thickening of basal membrane of retinal capillaries (glycoproteins)Thickening of basal membrane of retinal capillaries (glycoproteins) Failure of outer and inner blood retinal barrierFailure of outer and inner blood retinal barrier Patophysiology of diabetic retinopathy

22. 1.Nonproliferative DR (NPDR) 2.Proliferative DR (PDR) 3.Diabetic maculopathy (M) (each level of diabetic retinopathy may or may not beaccompanied by diabetic maculopathy) (each level of diabetic retinopathy may or may not beaccompanied by diabetic maculopathy) 1.Nonproliferative DR (NPDR) 2.Proliferative DR (PDR) 3.Diabetic maculopathy (M) (each level of diabetic retinopathy may or may not beaccompanied by diabetic maculopathy) (each level of diabetic retinopathy may or may not beaccompanied by diabetic maculopathy) Classification of diabetic retinopathy

23. Nonproliferative DR (NPDR) BeginningBeginning IntermediateIntermediate AdvancedAdvanced BeginningBeginning IntermediateIntermediate AdvancedAdvanced

24. Beginning NPDR

25. Intermediate NPDR

27. Advanced NPDR

28. Proliferative DR (PDR) LightLight IntermediateIntermediate Fully advanced VH- vitreous hemorrhage, PRH- preretinal hemorhage, TRD- retinal detachment at center of maculaFully advanced VH- vitreous hemorrhage, PRH- preretinal hemorhage, TRD- retinal detachment at center of macula LightLight IntermediateIntermediate Fully advanced VH- vitreous hemorrhage, PRH- preretinal hemorhage, TRD- retinal detachment at center of maculaFully advanced VH- vitreous hemorrhage, PRH- preretinal hemorhage, TRD- retinal detachment at center of macula

29. Light PDR

30. Intermediate PDR

31. Fully advanced PDR

33. Vitreous hemorrhage in fully advanced PDR

35. Diabetic maculopathy (M) affects 33% of diabetic patients after 8-10 years of duration of diseaseaffects 33% of diabetic patients after 8-10 years of duration of disease the most common cause of vision loss in diabetic retinopathythe most common cause of vision loss in diabetic retinopathy affects 33% of diabetic patients after 8-10 years of duration of diseaseaffects 33% of diabetic patients after 8-10 years of duration of disease the most common cause of vision loss in diabetic retinopathythe most common cause of vision loss in diabetic retinopathy

36. Diabetic makulopathy (M)

37. Macular area is a predilection site for edema formation Microangiopathy leads to ischemia, fluid accumulation, formation of microcysts and cysts Hard exudates (lipid accumulation) occur on the boundary of ischemic and normal retinaMacular area is a predilection site for edema formation Microangiopathy leads to ischemia, fluid accumulation, formation of microcysts and cysts Hard exudates (lipid accumulation) occur on the boundary of ischemic and normal retina Diabetic makulopathy (M)

39. Diabetic makulopathy (classification) Focal edemaFocal edema Difuse edemaDifuse edema Ischemic edema (rare)- avascular zone in maculaIschemic edema (rare)- avascular zone in macula Focal edemaFocal edema Difuse edemaDifuse edema Ischemic edema (rare)- avascular zone in maculaIschemic edema (rare)- avascular zone in macula

40. Focal edema

41. Difuse edema

42. Ischemic edema

43. Therapy of diabetic retinopathy and maculopathy Gold standard is laser photocoagulation of ischemic retinal partsGold standard is laser photocoagulation of ischemic retinal parts Laser can‘t be performed in central macular zoneLaser can‘t be performed in central macular zone Gold standard is laser photocoagulation of ischemic retinal partsGold standard is laser photocoagulation of ischemic retinal parts Laser can‘t be performed in central macular zoneLaser can‘t be performed in central macular zone

44. Laser therapy (technique) Laser therapy of DRLaser therapy of DR 1.focal 2.panretinal (scatter) Laser therapy of DRLaser therapy of DR 1.focal 2.panretinal (scatter)

45. Laser spots in retina suffered from NPDR

46. Laser therapy of diabetic maculopathyLaser therapy of diabetic maculopathy 1.focal 2.grid Laser therapy of diabetic maculopathyLaser therapy of diabetic maculopathy 1.focal 2.grid Laser therapy (technique)

48. Focal laser

50. Grid laser

51. Laser therapy (positives) Reducing of risc of visual lossReducing of risc of visual loss Reducing of risc of vitreous hemorrhage, neovascular glaucoma and tractional retinal detachmentReducing of risc of vitreous hemorrhage, neovascular glaucoma and tractional retinal detachment Reducing of risc of visual lossReducing of risc of visual loss Reducing of risc of vitreous hemorrhage, neovascular glaucoma and tractional retinal detachmentReducing of risc of vitreous hemorrhage, neovascular glaucoma and tractional retinal detachment

52. Laser therapy (negatives) Paliative treatmentPaliative treatment Dark adaptation problemsDark adaptation problems Paliative treatmentPaliative treatment Dark adaptation problemsDark adaptation problems

53. Surgical therapy of DR Pars plana vitrectomy- (Machemer, Parel – 1970)Pars plana vitrectomy- (Machemer, Parel – 1970)